Pharmaceutical

Tonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial Operations

Thomas brings more than 20 years of commercial and operations experience in the biopharmaceutical industry to Tonix Tonix is on…

1 year ago

C4 Therapeutics Announces Delivery of Second Development Candidate to Biogen

Milestone Results in $8 Million Payment to C4 Therapeutics WATERTOWN, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc.…

1 year ago

CELLTech(TM) DBS: Your Brain’s Healing Power Under Your Control

Trisha Pfluger, M.S., PMP, Chief Scientific Officer, and Nicholas Totagrande, CEO, Juno Biomedical, Inc. talk medical advancement, AI, and next…

1 year ago

Scout Launches ecoScout to Lower Carbon Footprint in Clinical Meetings

DALLAS, Sept. 9, 2024 /PRNewswire/ -- Scout, a leader in innovative services and technology, proudly introduces ecoScout, a first-in-market solution for…

1 year ago

WellSync and Marius Pharmaceuticals Collaborate to Offer FDA-approved Oral Testosterone Replacement Therapy, Expanding Virtual Care for Men’s Health

TAMPA, Fla., Sept. 9, 2024 /PRNewswire/ -- WellSync, a leader in telehealth innovation, is excited to announce a collaboration with…

1 year ago

Revitalist Announces Strategic Partnership with Sama Therapeutics to Advance Digital Human AI Agents for Precision Mental Health

Vancouver, British Columbia--(Newsfile Corp. - September 9, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO),…

1 year ago

Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis

TORONTO, ON / ACCESSWIRE / September 9, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical…

1 year ago